BIOMAT Database Logo BIOMAT Database Logo

Examination of polymorphism of 1-(p-chlorobenzoyl)-5-methoxy-2-methylindolyl-3-acetic acid. 1977

Z Galdecki, and M L Glówka, and Z Górkiewicz

UI MeSH Term Description Entries
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D003460 Crystallization The formation of crystalline substances from solutions or melts. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Crystalline Polymorphs,Polymorphism, Crystallization,Crystal Growth,Polymorphic Crystals,Crystal, Polymorphic,Crystalline Polymorph,Crystallization Polymorphism,Crystallization Polymorphisms,Crystals, Polymorphic,Growth, Crystal,Polymorph, Crystalline,Polymorphic Crystal,Polymorphisms, Crystallization,Polymorphs, Crystalline
D012997 Solvents Liquids that dissolve other substances (solutes), generally solids, without any change in chemical composition, as, water containing sugar. (Grant & Hackh's Chemical Dictionary, 5th ed) Solvent

Related Publications

Z Galdecki, and M L Glówka, and Z Górkiewicz
Substituted anilides of 1-(p-chlorobenzoyl)-5-methoxy-2-methyl-indole-3-acetic acid.
January 1973, Arzneimittel-Forschung,
Z Galdecki, and M L Glówka, and Z Górkiewicz
ANTI-INFLAMMATORY AND ANTIPYRETIC ACTIVITIES OF INDOMETHACIN, 1-(P-CHLOROBENZOYL)-5-METHOXY-2-METHYLINDOLE-3-ACETIC ACID.
September 1963, The Journal of pharmacology and experimental therapeutics,
Z Galdecki, and M L Glówka, and Z Górkiewicz
Crystal and molecular structure of an antiinflammatory agent, indomethacin, 1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid.
February 1972, Journal of the American Chemical Society,
Z Galdecki, and M L Glówka, and Z Górkiewicz
[On the pharmacology of 1-(p-chlorobenzoyl)-5-methoxy-2-methylindole acetic acid, a new antiphlogistic agent].
April 1965, Arzneimittel-Forschung,
Z Galdecki, and M L Glówka, and Z Górkiewicz
[Synthesis of 1-(p-chlorobenzoyl)-2-methyl-5-methoxyindolyl-3-acetic acid 2-,3- and 4-pyridylmethylamides].
January 1976, Acta poloniae pharmaceutica,
Z Galdecki, and M L Glówka, and Z Górkiewicz
The therapeutic activity of 1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid monohydrate glucosamide in rheumatoid arthritis (double blind trial).
March 1975, Arzneimittel-Forschung,
Z Galdecki, and M L Glówka, and Z Górkiewicz
[Preliminary observations on the clinical use of the glucosamide of N-p-chlorobenzoyl-2-methyl-5-methoxy-indol-3-acetic acid monohydrate].
January 1972, Reumatismo,
Z Galdecki, and M L Glówka, and Z Górkiewicz
Physiologic disposition and metabolic fate of indomethacin analogs. II. 1-(p-chlorobenzoyl)-5-dimethylamino-2-methylindole-3-acetic acid.
July 1971, Journal of pharmaceutical sciences,
Z Galdecki, and M L Glówka, and Z Górkiewicz
The disposition of the anti-inflammatory agent 14C-1-(p-chlorobenzoyl)-2-methyl-5-methoxy-3-indolylacetohydroxamic acid (oxametacine) in the rat.
January 1979, Arzneimittel-Forschung,
Z Galdecki, and M L Glówka, and Z Górkiewicz
Physiologic disposition and metabolic fate of indomethacin analogs. I. 1-p-chlorobenzylidenyl-5-methoxy-2-methylindene-3-acetic acid.
July 1971, Journal of pharmaceutical sciences,
Copied contents to your clipboard!